OXFORD, England--(BUSINESS WIRE)--Ochre Bio, a biotech company developing RNA medicines for chronic liver diseases, today announced the closing of a $9.6M seed financing round led by Khosla Ventures, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results